Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 17:15 ET | Source: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

Cash Runway Extended to Finance the Parkinson’s Program; Debt Paydown Improves Shareholder Equity Position Jupiter, FL, May 21, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS)...
May 19, 2026 09:00 ET | Source: Curia Global, Inc.

Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain

ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its...
May 19, 2026 00:30 ET | Source: Custom Market Insights

[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cholera Vaccine Market Size, Trends and Insights By Type (Whole Cell v. Cholerae...
May 18, 2026 07:05 ET | Source: Kraig Biocraft Laboratories

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications

Kraig Labs (OTCQB:KBLB) latest breakthrough could form the foundation for a next-generation biotechnology platform with potential applications in biopharma
May 14, 2026 12:30 ET | Source: Custom Market Insights

[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Transgenic Animals Market Size, Trends and Insights By Type (Mice, Rats, Rabbits,...
May 13, 2026 10:00 ET | Source: Oncotelic Therapeutics, Inc.

Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus

SAN DIEGO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic (OTCQB: OTLC) today announced that the first patient has been dosed in the Phase 1b clinical trial of Sapu003,...
May 12, 2026 09:30 ET | Source: Cellectis Inc.

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to...
May 12, 2026 09:30 ET | Source: Cellectis Inc.

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

NEW YORK, 12 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa plateforme pionnière d’édition du génome pour...
May 07, 2026 20:44 ET | Source: Odyssey Therapeutics Inc

Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering

Odyssey Therapeutics, Inc. announces pricing of its upsized IPO of 15,500,000 shares of its common stock at an IPO price of $18 per share.
May 04, 2026 16:30 ET | Source: Cellectis Inc.

Cellectis to Report First Quarter Financial Results on May 11, 2026

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...